Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (241-250 of 499) with videos related to

Pageof 50
Sort By:
The Lancet. Oncology|May 22, 2012
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trialsDiether Lambrechts, Bart Claes, Paul Delmar, et al.
The Lancet. Oncology|November 3, 2009
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009Donald Poon, Benjamin O Anderson, Li-Tzong Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2022
Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysisTiuri E Kroese, Hanneke W M van Laarhoven, Magnus Nilsson, et al.
Cancer Treatment Reviews|June 18, 2013
What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation?Roel C J Schlijper, Janneke P C Grutters, Ruud Houben, et al.
The Oncologist|August 19, 2023
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal CancerEric Van Cutsem, Rona Yaeger, Jean-Pierre Delord, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinomaEric Van Cutsem, Emilio Bajetta, Juan Valle, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2013
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trialJosep Tabernero, Eric Van Cutsem, Radek Lakomý, et al.
Annals of Surgical Oncology|April 25, 2012
Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancerUday Bharat Patel, Gina Brown, Harm Rutten, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 1, 2022
Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxomaViktor Proesmans, Tom Vandaele, Jan Van Slambrouck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusEric Van Cutsem, Claus-Henning Köhne, István Láng, et al.
Pageof 50

Showing results (241-250 of 499) with videos related to

Sort By:
Pageof 50
The Lancet. Oncology|May 22, 2012
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trialsDiether Lambrechts, Bart Claes, Paul Delmar, et al.
The Lancet. Oncology|November 3, 2009
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009Donald Poon, Benjamin O Anderson, Li-Tzong Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2022
Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysisTiuri E Kroese, Hanneke W M van Laarhoven, Magnus Nilsson, et al.
Cancer Treatment Reviews|June 18, 2013
What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation?Roel C J Schlijper, Janneke P C Grutters, Ruud Houben, et al.
The Oncologist|August 19, 2023
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal CancerEric Van Cutsem, Rona Yaeger, Jean-Pierre Delord, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinomaEric Van Cutsem, Emilio Bajetta, Juan Valle, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2013
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trialJosep Tabernero, Eric Van Cutsem, Radek Lakomý, et al.
Annals of Surgical Oncology|April 25, 2012
Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancerUday Bharat Patel, Gina Brown, Harm Rutten, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 1, 2022
Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxomaViktor Proesmans, Tom Vandaele, Jan Van Slambrouck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusEric Van Cutsem, Claus-Henning Köhne, István Láng, et al.
Pageof 50